Anixa Biosciences (ANIX) Receivables - Other (2013)

Anixa Biosciences' (ANIX) quarterly Receivables - Other came in at $2000.0 in Q2 2013, little changed on a QoQ basis from $2000.0 in Q1 2013.

Anixa Biosciences (ANIX) Receivables - Other (2013) Analysis & Trends

Anixa Biosciences (ANIX) has 1 years of Receivables - Other data on file, last reported at $2000.0 in Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Anixa Biosciences	121.44 Mn	121.44 Mn	-

Download Data